FDA Approves GSK's BENLYSTA as the First Medicine for Adult Patients with Active Lupus Nephritis in the US

Approval builds on nearly 10 years of experience in lupus LONDON, Dec. 17, 2020 -- (Healthcare Sales & Marketing Network) -- GlaxoSmithKline plc (LSE/NYSE: GSK) announced the US Food and Drug Administration (FDA) has approved BENLYSTA (belimumab) for t... Biopharmaceuticals, FDA GlaxoSmithKline, BENLYSTA, belimumab, lupus nephritis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news